Dashboard
Manage Tickers

NLTXNeurogene Inc.


$ 1.59 (3.94 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
$ 12.49 - $ 53.00
88,632
na
9.69M
$ 3.64
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

neoleukin-therapeutics-plans-for-1-for-4-reverse-stock-split
Neoleukin Therapeutics Plans For 1-For-4 R...
12/15/2023 07:02:29

The reverse stock split will become effective at 12:02 a.m., Eastern Time on December 18, 2023.

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
10/05/2023 13:10:42

why-orchard-therapeutics-shares-are-trading-higher-by-around-95-here-are-20-stocks-moving-premarket
Why Orchard Therapeutics Shares Are Tradin...
10/05/2023 12:15:22

Gainers

neoleukin-therapeutics-plans-1-for-5-reverse-stock-split
Neoleukin Therapeutics Plans 1-For-5 Rever...
09/22/2023 12:03:00

The reverse stock split will become effective at 12:01 a.m. Eastern time on September 25, 2023. 

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
08/17/2023 21:32:21

neoleukin-therapeutics-to-merge-with-neurogene-creates-biotech-firm-focused-on-genetic-medicines-for-neurological-diseases
Neoleukin Therapeutics To Merge With Neuro...
07/18/2023 13:26:18

Privately-held Neurogene Inc has agreed to merge with Neoleukin Therapeutics Inc (NASDAQ: NLTX) in 

neurogene-neoleukin-therapeutics-enter-definitive-merger-agreement-to-combine-in-an-all-stock-transaction
Neurogene, Neoleukin Therapeutics Enter De...
07/18/2023 10:32:18

The combined company is expected to operate under the name Neurogene Inc. and trade on the Nasdaq Capital Market under the tick...

mizuho-maintains-neutral-on-neoleukin-therapeutics-lowers-price-target-to-15
Mizuho Maintains Neutral on Neoleukin Ther...
05/09/2023 14:04:25

Mizuho analyst Mara Goldstein maintains Neoleukin Therapeutics (NASDAQ:NLTX) with a Neutral and lowers the price target from...

us-stocks-turn-lower-sp-500-down-1
US Stocks Turn Lower; S&P 500 Down 1%
03/09/2023 19:25:07

U.S. stocks turned lower toward the end of trading, with the Dow Jones dropping around 300 points on Thursday. The Dow traded ...

why-jdcom-shares-are-trading-lower-by-around-9-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why JD.com Shares Are Trading Lower By Aro...
03/09/2023 18:10:32

Gainers

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
03/09/2023 17:31:07

us-stocks-pare-gains-bjs-wholesale-club-earnings-top-views
US Stocks Pare Gains; BJ's Wholesale Club ...
03/09/2023 17:30:38

U.S. stocks traded slightly higher midway through trading, with the Nasdaq Composite gaining 20 points on Thursday. The Dow tr...

neoleukin-therapeutics-seeks-strategic-alternatives-to-layoff-more-in-round-2-within-6-months
Neoleukin Therapeutics Seeks Strategic Alt...
03/09/2023 13:41:51

Neoleukin Therapeutics Inc (NASDAQ: NLTX) has engaged SVB Securities to assist in reviewing strategic alternatives. 

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
03/09/2023 13:06:33

why-cassava-sciences-shares-are-trading-higher-by-12-here-are-20-stocks-moving-premarket
Why Cassava Sciences Shares Are Trading Hi...
03/09/2023 12:43:48

Gainers

reported-late-wednesday-march-08-neoleukin-board-of-directors-approved-a-further-corporate-restructuring-to-preserve-cash-including-a-reduction-in-the-companys-workforce-by-70
Reported Late Wednesday March 08, Neoleuki...
03/09/2023 05:31:20

In connection with the evaluation of strategic alternatives, the Board of Directors of Neoleukin also approved a further corpor...

reported-late-wednesday-march-08-neoleukin-therapeutics-provides-strategic-update-and-announces-restructuring-and-leadership-transition-chief-executive-officer-jonathan-drachman-md-will-be-stepping-down-after-a-short-transition
Reported Late Wednesday March 08, Neoleuki...
03/09/2023 05:29:55

Neoleukin Therapeutics, Inc., "Neoleukin" (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computatio...

guggenheim-downgrades-neoleukin-therapeutics-to-neutral
Guggenheim Downgrades Neoleukin Therapeuti...
01/03/2023 12:10:11

Guggenheim analyst Charles Zhu downgrades Neoleukin Therapeutics (NASDAQ:NLTX) from Buy to Neutral.

neoleukin-therapeutics-presents-preclinical-data-on-neo-tra1-at-american-society-of-hematology-annual-meeting
Neoleukin Therapeutics Presents Preclinica...
12/12/2022 18:01:46

Neoleukin Therapeutics, Inc., "Neoleukin" (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computatio...

stocks-that-hit-52-week-lows-on-thursday
Stocks That Hit 52-Week Lows On Thursday
11/17/2022 15:44:54

  OnThursday, 137 stocks made new 52-week lows.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION